Citations 1
Randomized multicenter phase II trial of timed-sequential therapy with flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus “7+3” for adults with newly diagnosed acute myeloid leukemia (AML).
Litzow, Mark R. , Morris, Lawrence E. , Levy, Moshe , Gojo, Ivana , Gocke, Christopher D. , Rosner, Gary L. , Greer, Jacqueline M., Cain, Joan McFadden, Little, Richard F. , Wright, John Joseph, Doyle, L. Austin, Karp, Judith E. , Zeidner, Joshua F. , Foster, Matthew C , Blackford, Amanda , Strickland, Stephen Anthony , Lancet, Jeffrey E. , Bose, Prithviraj , Tibes, Raoul , Smith, B. Douglas
Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 7002-7002
